The Cardiopulmonary Exercise Testing Market is led by CPET metabolic carts, which remain the dominant product category. These systems combine exercise equipment with respiratory and metabolic measurements to provide clinicians with comprehensive information about a patient's physiological response to exercise.

Market Research Future reports that the CPET metabolic carts segment was valued at approximately USD 0.576 billion in 2024. Software represents a smaller but rapidly growing segment, supported by improvements in data analysis, visualization, and integration with digital healthcare systems.

Modern software platforms can process large volumes of test data and provide clinicians with clearer insights into exercise capacity and cardiopulmonary performance.

The combination of advanced hardware and analytical software is expected to remain an important area of product innovation.